NXP Semiconductors (NXPI) 10-Q 7 Nov 23 2023 Q3 Quarterly report Financial data

Cover Document

Cover Document - shares	9 Months Ended
	Oct. 01, 2023	Nov. 03, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 01, 2023
Document Transition Report	false
Entity File Number	001-34841
Entity Registrant Name	NXP Semiconductors N.V.
Entity Incorporation, State or Country Code	P7
Entity Tax Identification Number	98-1144352
Entity Address, Address Line One	60 High Tech Campus
Entity Address, City or Town	Eindhoven
Entity Address, Country	NL
Entity Address, Postal Zip Code	5656 AG
Country Region	+31
City Area Code	40
Local Phone Number	2729999
Title of 12(b) Security	Common shares, EUR 0.20 par value
Trading Symbol	NXPI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		257,763,301
Amendment Flag	false
Entity Central Index Key	0001413447
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Income Statement [Abstract]
Revenue	$ 3,434	$ 3,445	$ 9,854	$ 9,893
Cost of revenue	(1,469)	(1,478)	(4,238)	(4,267)
Gross profit	1,965	1,967	5,616	5,626
Research and development	(601)	(548)	(1,767)	(1,608)
Selling, general and administrative	(294)	(289)	(848)	(805)
Amortization of acquisition-related intangible assets	(71)	(131)	(237)	(400)
Total operating expenses	(966)	(968)	(2,852)	(2,813)
Other income (expense)	(7)	2	(10)	4
Operating income (loss)	992	1,001	2,754	2,817
Financial income (expense):
Other financial income (expense)	(75)	(98)	(231)	(313)
Income (loss) before income taxes	917	903	2,523	2,486
Benefit (provision) for income taxes	(123)	(149)	(399)	(392)
Results relating to equity-accounted investees	(2)	(4)	(5)	5
Net income (loss)	792	750	2,119	2,099
Less: Net income (loss) attributable to non-controlling interests	5	12	19	34
Net income (loss) attributable to stockholders	$ 787	$ 738	$ 2,100	$ 2,065
Earnings per share data:
Basic net income (loss) (in dollars per share)	$ 3.06	$ 2.81	$ 8.12	$ 7.86
Diluted net income (loss) (in dollars per share)	$ 3.01	$ 2.79	$ 8.03	$ 7.80
Weighted average number of shares of common stock outstanding during the period (in thousands):
Basic (in shares)	257,488	262,180	258,744	262,620
Diluted (in shares)	261,095	264,705	261,666	264,838
(Gain) loss on extinguishment of debt	$ 0	$ 0	$ 0	$ (18)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 792	$ 750	$ 2,119	$ 2,099
Other comprehensive income (loss), net of tax:
Change in fair value cash flow hedges	(2)	(13)	(12)	(25)
Change in foreign currency translation adjustment	(45)	(78)	(24)	(165)
Total other comprehensive income (loss)	(47)	(90)	(36)	(190)
Total comprehensive income (loss)	745	660	2,083	1,909
Less: Comprehensive income (loss) attributable to non-controlling interests	5	12	19	34
Total comprehensive income (loss) attributable to stockholders	740	648	2,064	1,875
Change in net actuarial gain (loss)	$ 0	$ 1	$ 0	$ 0

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) $ in Millions	Oct. 01, 2023 USD ($)	Dec. 31, 2022 USD ($)
Current assets:
Cash and cash equivalents	$ 4,042	$ 3,845
Accounts receivable, net	939	960
Inventories, net	2,140	1,782
Other current assets	495	348
Total current assets	7,616	6,935
Non-current assets:
Other non-current assets	2,236	1,942
Property, plant and equipment, net of accumulated depreciation of $5,525 and $5,214	3,197	3,105
Identified intangible assets, net of accumulated amortization of $1,565 and $1,883	1,010	1,311
Goodwill	9,937	9,943
Total non-current assets	16,380	16,301
Total assets	23,996	23,236
Current liabilities:
Accounts payable	959	1,185
Restructuring liabilities-current	16	19
Other current liabilities	1,990	2,066
Short-term debt	999	0
Total current liabilities	3,964	3,270
Non-current liabilities:
Long-term debt	10,173	11,165
Restructuring liabilities	3	1
Deferred tax liabilities	44	45
Other non-current liabilities	1,014	1,015
Total non-current liabilities	11,234	12,226
Total liabilities	15,198	15,496
Equity:
Non-controlling interests	310	291
Stockholders’ equity:
Common stock, par value €0.20 per share:	56	56
Capital in excess of par value	14,398	14,091
Treasury shares, at cost : 36,518,520 shares (2019: 34,082,242 shares)	(3,281)	(2,799)
Accumulated other comprehensive income (loss)	40	76
Accumulated deficit	(2,725)	(3,975)
Total stockholders’ equity	8,488	7,449
Total equity	8,798	7,740
Total liabilities and equity	$ 23,996	$ 23,236

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) $ in Millions	Oct. 01, 2023 USD ($) shares	Oct. 01, 2023 € / shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2022 € / shares
Statement of Financial Position [Abstract]
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	$ 5,525		$ 5,214
Accumulated amortization	$ (1,565)		$ (1,883)
Common stock, par value (in euros per share) | € / shares		€ 0.20		€ 0.20
Treasury shares (in shares) | shares	17,569,471		15,056,232

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022
Cash flows from operating activities:
Net income (loss)	$ 2,119	$ 2,099
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	837	948
Share-based compensation	304	267
Amortization of discount (premium) on debt, net	2	2
Amortization of debt issuance costs	6	5
Net (gain) loss on sale of assets	(1)	(2)
(Gain) loss on equity security, net	(1)	6
(Gain) loss on extinguishment of debt	0	18
Results relating to equity-accounted investees	5	(5)
Deferred tax expense (benefit)	(170)	(196)
Changes in operating assets and liabilities:
(Increase) decrease in receivables and other current assets	(118)	(165)
(Increase) decrease in inventories	(359)	(392)
Increase (decrease) in accounts payable and other liabilities	(220)	545
Decrease (increase) in other non-current assets	(49)	(325)
Exchange differences	15	(2)
Other items	6	16
Net cash provided by (used for) operating activities	2,376	2,819
Cash flows from investing activities:
Purchase of identified intangible assets	(135)	(122)
Capital expenditures on property, plant and equipment	(652)	(830)
Payments to Acquire Equipment on Lease	0	(5)
Proceeds from disposals of property, plant and equipment	1	2
Purchase of interests in businesses, net of cash acquired	0	(27)
Purchase of investments	(93)	(9)
Proceeds from Sale of Other Investments	0	12
Proceeds from sale of investments	0	2
Net cash provided by (used for) investing activities	(879)	(977)
Cash flows from financing activities:
Repayments of Notes Payable	0	(917)
Proceeds from the issuance of long-term debt	0	1,496
Cash paid for debt issuance costs	0	(13)
Dividends paid to common stockholders	(745)	(594)
Proceeds from issuance of common stock through stock plans	70	58
Purchase of treasury shares and restricted stock unit withholdings	(619)	(920)
Proceeds from (Payments for) Other Financing Activities	(2)	(1)
Net cash provided by (used for) financing activities	(1,296)	(891)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(4)	(22)
Increase (decrease) in cash and cash equivalents	197	929
Cash and cash equivalents at beginning of period	3,845	2,830
Cash and cash equivalents at end of period	4,042	3,759
Net cash paid during the period for:
Interest	178	217
Income taxes, net of refunds	698	432
Cash proceeds from the sale of assets	1	2
Non-cash capital expenditures	$ 167	$ 176

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common stock	Capital in excess of par value	Treasury shares at cost	Accumulated other comprehensive income (loss)	Accumulated deficit	Total stock- holders’ equity	Non- controlling interests
Shares, Issued, Beginning Balance at Dec. 31, 2021		264,950
Beginning balance at Dec. 31, 2021	$ 6,770	$ 56	$ 13,727	$ (1,932)	$ 48	$ (5,371)	$ 6,528	$ 242
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	666					657	657	9
Other comprehensive income (loss)	(22)				(22)		(22)
Share-based compensation plans	92		92				92
Shares issued pursuant to stock awards (in shares)		256
Shares issued pursuant to stock awards	28			51		(23)	28
Treasury share repurchase and retired (in shares)		(2,653)
Treasury shares repurchased and retired	$ (552)			(552)			(552)
Dividends common stock (in dollars per share)	$ 0.845
Dividends common stock	$ (222)					(222)	(222)
Balance (in shares) at Apr. 03, 2022		262,553
Ending balance at Apr. 03, 2022	6,760	$ 56	13,819	(2,433)	26	(4,959)	6,509	251
Shares, Issued, Beginning Balance at Dec. 31, 2021		264,950
Beginning balance at Dec. 31, 2021	6,770	$ 56	13,727	(1,932)	48	(5,371)	6,528	242
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,099
Other comprehensive income (loss)	(190)
Balance (in shares) at Oct. 02, 2022		260,389
Ending balance at Oct. 02, 2022	7,385	$ 56	13,996	(2,765)	(142)	(4,039)	7,106	279
Shares, Issued, Beginning Balance at Apr. 03, 2022		262,553
Beginning balance at Apr. 03, 2022	6,760	$ 56	13,819	(2,433)	26	(4,959)	6,509	251
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	683					670	670	13
Other comprehensive income (loss)	(78)				(78)		(78)
Share-based compensation plans	85		85				85
Shares issued pursuant to stock awards (in shares)		57
Shares issued pursuant to stock awards	0			11		(11)	0
Treasury share repurchase and retired (in shares)		(15)
Treasury shares repurchased and retired	$ (2)			(2)			(2)
Dividends common stock (in dollars per share)	$ 0.845
Dividends common stock	$ (222)					(222)	(222)
Balance (in shares) at Jul. 03, 2022		262,595
Ending balance at Jul. 03, 2022	7,226	$ 56	13,904	(2,424)	(52)	(4,522)	6,962	264
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	750					738	738	12
Other comprehensive income (loss)	(90)				(90)		(90)
Share-based compensation plans	92		92				92
Shares issued pursuant to stock awards (in shares)		295
Shares issued pursuant to stock awards	30			60		(30)	30
Treasury share repurchase and retired (in shares)		(2,501)
Treasury shares repurchased and retired	$ (401)			(401)			(401)
Dividends common stock (in dollars per share)	$ 0.845
Dividends common stock	$ (222)					(222)	(222)
Balance (in shares) at Oct. 02, 2022		260,389
Ending balance at Oct. 02, 2022	7,385	$ 56	13,996	(2,765)	(142)	(4,039)	7,106	279
Shares, Issued, Beginning Balance at Dec. 31, 2022		259,463
Beginning balance at Dec. 31, 2022	7,740	$ 56	14,091	(2,799)	76	(3,975)	7,449	291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	623					615	615	8
Other comprehensive income (loss)	22				22		22
Share-based compensation plans	101		101				101
Shares issued pursuant to stock awards (in shares)		309
Shares issued pursuant to stock awards	33			61		(28)	33
Treasury share repurchase and retired (in shares)		(37)
Treasury shares repurchased and retired	$ (7)			(7)			(7)
Dividends common stock (in dollars per share)	$ 1.014
Dividends common stock	$ (264)					(264)	(264)
Balance (in shares) at Apr. 02, 2023		259,735
Ending balance at Apr. 02, 2023	8,248	$ 56	14,192	(2,745)	98	(3,652)	7,949	299
Shares, Issued, Beginning Balance at Dec. 31, 2022		259,463
Beginning balance at Dec. 31, 2022	7,740	$ 56	14,091	(2,799)	76	(3,975)	7,449	291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,119
Other comprehensive income (loss)	(36)
Balance (in shares) at Oct. 01, 2023		256,950
Ending balance at Oct. 01, 2023	8,798	$ 56	14,398	(3,281)	40	(2,725)	8,488	310
Shares, Issued, Beginning Balance at Apr. 02, 2023		259,735
Beginning balance at Apr. 02, 2023	8,248	$ 56	14,192	(2,745)	98	(3,652)	7,949	299
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	704					698	698	6
Other comprehensive income (loss)	(11)				(11)		(11)
Share-based compensation plans	99		99				99
Shares issued pursuant to stock awards (in shares)		71
Shares issued pursuant to stock awards	1			13		(12)	1
Treasury share repurchase and retired (in shares)		(1,681)
Treasury shares repurchased and retired	$ (302)			(302)			(302)
Dividends common stock (in dollars per share)	$ 1.014
Dividends common stock	$ (262)					(262)	(262)
Balance (in shares) at Jul. 02, 2023		258,125
Ending balance at Jul. 02, 2023	8,477	$ 56	14,291	(3,034)	87	(3,228)	8,172	305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	792					787	787	5
Other comprehensive income (loss)	(47)				(47)		(47)
Share-based compensation plans	107		107				107
Shares issued pursuant to stock awards (in shares)		299
Shares issued pursuant to stock awards	36			59		(23)	36
Treasury share repurchase and retired (in shares)		(1,474)
Treasury shares repurchased and retired	$ (306)			(306)			(306)
Dividends common stock (in dollars per share)	$ 1.014
Dividends common stock	$ (261)					(261)	(261)
Balance (in shares) at Oct. 01, 2023		256,950
Ending balance at Oct. 01, 2023	$ 8,798	$ 56	$ 14,398	$ (3,281)	$ 40	$ (2,725)	$ 8,488	$ 310

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) (Parenthetical) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Oct. 01, 2023	Jul. 02, 2023	Apr. 02, 2023	Oct. 02, 2022	Jul. 03, 2022	Apr. 03, 2022	Oct. 01, 2023	Oct. 02, 2022	Dec. 31, 2022	Dec. 31, 2021
Statement of Stockholders' Equity [Abstract]
Dividends common stock (in dollars per share)	$ 1.014	$ 1.014	$ 1.014	$ 0.845	$ 0.845	$ 0.845
Net income (loss)	$ 792	$ 704	$ 623	$ 750	$ 683	$ 666	$ 2,119	$ 2,099
Other comprehensive income (loss)	(47)	(11)	22	(90)	(78)	(22)	(36)	(190)
Share-based compensation plans	107	99	101	92	85	92
Shares issued pursuant to stock awards	36	1	33	30	0	28
Treasury shares repurchased and retired	(306)	(302)	(7)	(401)	(2)	(552)
Dividends common stock	(261)	(262)	(264)	(222)	(222)	(222)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 8,798	$ 8,477	$ 8,248	$ 7,385	$ 7,226	$ 6,760	$ 8,798	$ 7,385	$ 7,740	$ 6,770

Basis of Presentation and Overv

Basis of Presentation and Overview	9 Months Ended
	Oct. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Overview	Basis of Presentation and Overview We prepared our interim condensed consolidated financial statements that accompany these notes in conformity with U.S. generally accepted accounting principles, consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended December 31, 2022. We have made estimates and judgments affecting the amounts reported in our condensed consolidated financial statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, but reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022.

Significant Accounting Policies

Significant Accounting Policies and Recent Accounting Pronouncements	9 Months Ended
	Oct. 01, 2023
Accounting Policies [Abstract]
Significant Accounting Policies and Recent Accounting Pronouncements	Significant Accounting Policies and Recent Accounting Pronouncements Significant Accounting Policies For a discussion of our significant accounting policies see, “Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2022. There have been no changes to our significant accounting policies since our Annual Report on Form 10-K for the year ended December 31, 2022. Accounting standards recently adopted In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. ASU 2022-04, which require that a buyer in a supplier finance program to disclose sufficient information about the program, is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. ASU 2022-04 became effective for us on January 1, 2023. We have assessed our current positions and the interrelation to the amendments and the adoption of this update did not have a material impact on the Company's consolidated financial statements and related disclosures. No other new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.

Supplemental Financial Informat

Supplemental Financial Information	9 Months Ended
	Oct. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Financial Information	Supplemental Financial Information Statement of Operations Information: Disaggregation of revenue The following table presents revenue disaggregated by sales channel: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Distributors 1,947 1,876 5,117 5,385 Original Equipment Manufacturers and Electronic Manufacturing Services 1,463 1,525 4,653 4,378 Other 24 44 84 130 Total 3,434 3,445 9,854 9,893 Depreciation, amortization and impairment For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Depreciation of property, plant and equipment 163 156 485 447 Amortization of internal use software 5 3 14 9 Amortization of other identified intangible assets 105 162 338 492 Total - Depreciation, amortization and impairment 273 321 837 948 Financial income and expense For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Interest income 49 21 134 29 Interest expense (109) (109) (329) (319) Total other financial income/ (expense) (15) (10) (36) (41) Total (75) (98) (231) (331) Earnings per share The computation of earnings per share (EPS) is presented in the following table: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Net income (loss) 792 750 2,119 2,099 Less: net income (loss) attributable to non-controlling interests 5 12 19 34 Net income (loss) attributable to stockholders 787 738 2,100 2,065 Weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) 257,488 262,180 258,744 262,620 Plus incremental shares from assumed conversion of: Options 1) 182 275 193 297 Restricted Share Units, Performance Share Units and Equity Rights 2) 3,425 2,250 2,729 1,921 Dilutive potential common shares 3,607 2,525 2,922 2,218 Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) 261,095 264,705 261,666 264,838 EPS attributable to stockholders in $: Basic net income (loss) 3.06 2.81 8.12 7.86 Diluted net income (loss) 3.01 2.79 8.03 7.80 1) There were no stock options to purchase shares of NXP’s common stock that were outstanding in Q3 2023 and YTD 2023 (Q3 2022 and YTD 2022: no shares) that were anti-dilutive and were not included in the computation of diluted EPS because the exercise price was greater than the average fair market value of the common stock or the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense and exercise prices were greater than the weighted average number of shares underlying outstanding stock options. 2) There were no unvested RSUs, PSUs and equity rights that were outstanding in Q3 2023 and YTD 2023 (Q3 2022 and YTD 2022: 0.3 million shares) that were anti-dilutive and were not included in the computation of diluted EPS because the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense were greater than the weighted average number of outstanding unvested RSUs, PSUs and equity rights or the performance goal has not been met yet. Balance Sheet Information Cash and cash equivalents At October 1, 2023 and December 31, 2022, our cash balance was $4,042 million and $3,845 million, respectively, of which $225 million and $227 million was held by SSMC, our consolidated joint venture company with TSMC. Under the terms of our joint venture agreement with TSMC, a portion of this cash can be distributed by way of a dividend to us, but 38.8% of the dividend will be paid to our joint venture partner. During both first nine months of 2023 and 2022, no dividends were declared by SSMC. Inventories The portion of finished goods stored at customer locations under consignment amounted to $10 million as of October 1, 2023 (December 31, 2022: $8 million). Inventories are summarized as follows: October 1, 2023 December 31, 2022 Raw materials 121 151 Work in process 1,664 1,308 Finished goods 355 323 2,140 1,782 The amounts recorded above are net of allowance for obsolescence of $153 million as of October 1, 2023 (December 31, 2022: $125 million). Equity Investments At October 1, 2023 and December 31, 2022, the total carrying value of investments in equity securities is summarized as follows: October 1, 2023 December 31, 2022 Marketable equity securities 12 9 Non-marketable equity securities 55 18 Equity-accounted investments 102 71 169 98 The total carrying value of investments in equity-accounted investees is summarized as follows: October 1, 2023 December 31, 2022 Shareholding % Amount Shareholding % Amount SMART Growth Fund, L.P. 8.41 % 41 8.41 % 38 SigmaSense, LLC 10.64 % 34 — — Others — 27 — 33 102 71 Results related to equity-accounted investees at the end of each period were as follows: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Company's share in income (loss) (2) (5) (5) 3 Other results — 1 — 2 (2) (4) (5) 5 Other current liabilities Other current liabilities at October 1, 2023 and December 31, 2022 consisted of the following: October 1, 2023 December 31, 2022 Accrued compensation and benefits 477 467 Customer programs 408 432 Income taxes payable 187 296 Dividend payable 261 219 Other 657 652 1,990 2,066 We have reclassified certain amounts related to customer programs previously presented in “Accounts payable” to “Other current liabilities” as of December 31, 2022 to conform to current period presentation as follows: December 31, Accounts payable: As reported 1,617 Reclassification - customer programs (432) Adjusted 1,185 Other current liabilities: As reported 1,634 Reclassification - customer programs 432 Adjusted 2,066 Accumulated other comprehensive income (loss) Total comprehensive income (loss) represents net income (loss) plus the results of certain equity changes not reflected in the condensed consolidated statements of operations. The after-tax components of accumulated other comprehensive income (loss) and their corresponding changes are shown below: Currency Change in fair Net actuarial Accumulated As of December 31, 2022 135 (1) (58) 76 Other comprehensive income (loss) before (24) (26) — (50) Amounts reclassified out of accumulated other — 10 — 10 Tax effects — 4 — 4 Other comprehensive income (loss) (24) (12) — (36) As of October 1, 2023 111 (13) 58 40 Cash dividends The following dividends were declared during the first three quarters of 2023 and 2022 under NXP’s quarterly dividend program: Fiscal year 2023 Fiscal year 2022 Dividend per share Amount Dividend per share Amount First quarter 1.014 263 0.845 222 Second quarter 1.014 263 0.845 222 Third quarter 1.014 261 0.845 221 The dividend declared in the third quarter (not yet paid) is classified in the condensed consolidated balance sheet in other current liabilities as of October 1, 2023 and was subsequently paid on October 5, 2023.

Restructuring

Restructuring	9 Months Ended
	Oct. 01, 2023
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring At each reporting date, we evaluate our restructuring liabilities, which consist primarily of termination benefits, to ensure that our accruals are still appropriate. The following table presents the changes in restructuring liabilities in 2023: As of January 1, 2023 Additions Utilized Released Other As of October 1, 2023 Restructuring liabilities 20 21 (13) (7) (2) 19 The total restructuring liability as of October 1, 2023 of $19 million is classified in the consolidated balance sheet under current liabilities ($16 million) and non-current liabilities ($3 million). The restructuring charges for the nine month period ending October 1, 2023 consist of $21 million for personnel related costs for a new restructuring program, offset by a $7 million release for an earlier program. There were no significant restructuring costs incurred for the nine month period ended October 2, 2022 and the utilization of the restructuring liabilities mainly reflects the execution of ongoing restructuring programs the Company initiated in earlier years. These restructuring charges recorded in operating income, for the periods indicated, are included in the following line items in the statement of operations: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Cost of revenue — — (2) (3) Research and development (4) — 10 (2) Selling, general and administrative — — 6 — Net restructuring charges (4) — 14 (5)

Income Taxes

Income Taxes	9 Months Ended
	Oct. 01, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Tax For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Benefit (provision) for income taxes (123) (149) (399) (392) Effective tax rate 13.4 % 16.5 % 15.8 % 15.8 % Statutory income tax rate in the Netherlands 25.8 % 25.8 % 25.8 % 25.8 % Beginning with the first quarter of 2023, NXP was in a position to make a reliable estimate of its annual effective tax rate. This estimated annual effective tax rate ("EAETR") is then applied to the year-to-date Income (loss) before income taxes excluding discrete items, to determine the year-to-date benefit (provision) for income taxes. The income tax effects of any discrete items are recognized in the interim period in which they occur. As the year progresses, the Company continually refines the EAETR based upon actual events and the apportionment of our earnings (loss). This continual estimation process periodically may result in a change to our EAETR for the year. When this occurs, we adjust on an accumulated basis the benefit (provision) for income taxes during the quarter in which the change occurs. Our provision for income taxes for 2023 is based on our EAETR of 16.1%, which is lower than the Netherlands statutory tax rate of 25.8%, primarily due to tax benefits from the Netherlands and foreign tax incentives. The effective tax rate of 13.4% for the third quarter of 2023 was lower than the EAETR due to the income tax benefit for discrete items of $12 million. The discrete items are primarily related to changes in estimates for previous years, and the impact of foreign currency on income tax related items. Compared to prior quarters, the EAETR was lower due to a recapture of $13 million tax benefit in the third quarter primarily as a result of new guidance released by the Internal Revenue Service to clarify the treatment of specified research and experimental expenditures under Section 174. For the first nine months of 2023 the effective tax rate of 15.8% was lower than 16.1% due to the net result of favorable discrete items of $8 million. The effective tax rate of 15.8% for the first nine months of 2022 was equal to the current period of 15.8%.

Identified Intangible Assets

Identified Intangible Assets	9 Months Ended
	Oct. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Identified Intangible Assets	Identified Intangible Assets Identified intangible assets as of October 1, 2023 and December 31, 2022, respectively, were composed of the following: October 1, 2023 December 31, 2022 Gross carrying Accumulated Gross carrying Accumulated In-process R&D (IPR&D) 1) 70 — 70 — Customer-related 788 (341) 788 (307) Technology-based 1,717 (1,224) 2,336 (1,576) Identified intangible assets 2,575 (1,565) 3,194 (1,883) 1) IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort. The estimated amortization expense for these identified intangible assets for each of the five succeeding years is: 2023 (remaining) 101 2024 291 2025 168 2026 88 2027 61 Thereafter 301 All intangible assets, excluding IPR&D and goodwill, are subject to amortization and have no assumed residual value. The expected weighted average remaining life of identified intangibles is 4 years as of October 1, 2023 (December 31, 2022: 4 years).

Debt

Debt	9 Months Ended
	Oct. 01, 2023
Debt Disclosure [Abstract]
Debt	Debt The following table summarizes the outstanding debt as of October 1, 2023 and December 31, 2022: October 1, 2023 December 31, 2022 Maturities Amount Interest Amount Interest Fixed-rate 4.875% senior unsecured notes Mar, 2024 1,000 4.875 1,000 4.875 Fixed-rate 2.7% senior unsecured notes May, 2025 500 2.700 500 2.700 Fixed-rate 5.35% senior unsecured notes Mar, 2026 500 5.350 500 5.350 Fixed-rate 3.875% senior unsecured notes Jun, 2026 750 3.875 750 3.875 Fixed-rate 3.15% senior unsecured notes May, 2027 500 3.150 500 3.150 Fixed-rate 4.40% senior unsecured notes Jun, 2027 500 4.400 500 4.400 Fixed-rate 5.55% senior unsecured notes Dec, 2028 500 5.550 500 5.550 Fixed-rate 4.3% senior unsecured notes Jun, 2029 1,000 4.300 1,000 4.300 Fixed-rate 3.4% senior unsecured notes May, 2030 1,000 3.400 1,000 3.400 Fixed-rate 2.5% senior unsecured notes May, 2031 1,000 2.500 1,000 2.500 Fixed-rate 2.65% senior unsecured notes Feb, 2032 1,000 2.650 1,000 2.650 Fixed-rate 5.00% senior unsecured notes Jan, 2033 1,000 5.000 1,000 5.000 Fixed-rate 3.25% senior unsecured notes May, 2041 1,000 3.250 1,000 3.250 Fixed-rate 3.125% senior unsecured notes Feb, 2042 500 3.125 500 3.125 Fixed-rate 3.25% senior unsecured notes Nov, 2051 500 3.250 500 3.250 Floating-rate revolving credit facility (RCF) Aug, 2027 — — — — Total principal 11,250 11,250 Unamortized discounts, premiums and debt (78) (85) Total debt, including unamortized discounts, 11,172 11,165 Current portion of long-term debt (999) — Long-term debt 10,173 11,165

Related-Party Transactions

Related-Party Transactions	9 Months Ended
	Oct. 01, 2023
Related Party Transactions [Abstract]
Related-Party Transactions	Related-Party Transactions The Company's related parties are the members of the board of directors of NXP Semiconductors N.V., the executive officers of NXP Semiconductors N.V. and equity-accounted investees. The following table presents the amounts related to revenue and other income and purchase of goods and services incurred in transactions with these related parties: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Revenue and other income 2 2 3 7 Purchase of goods and services 1 1 2 3 The following table presents the amounts related to receivable and payable balances with these related parties: October 1, 2023 December 31, 2022 Receivables 1 1 Payables 7 3

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 01, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table summarizes the estimated fair value of our financial instruments which are measured at fair value on a recurring basis: Estimated fair value Fair value October 1, 2023 December 31, 2022 Assets: Money market funds 1 3,056 2,817 Marketable equity securities 1 12 9 Derivative instruments-assets 2 1 8 Liabilities: Derivative instruments-liabilities 2 (20) (6) The following methods and assumptions were used to estimate the fair value of financial instruments: Assets and liabilities measured at fair value on a recurring basis Investments in money market funds (as part of our cash and cash equivalents) and marketable equity securities (as part of other non-current assets) have fair value measurements which are all based on quoted prices in active markets for identical assets or liabilities. For derivatives (as part of other current assets or accrued liabilities) the fair value is based upon significant other observable inputs depending on the nature of the derivative. Assets and liabilities recorded at fair value on a non-recurring basis We measure and record our non-marketable equity securities, equity method investments and non-financial assets, such as intangible assets and property, plant and equipment, at fair value when an impairment charge is required. Assets and liabilities not recorded at fair value on a recurring basis Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period and debt. As of October 1, 2023, the estimated fair value of current and non-current debt was $9.6 billion ($9.8 billion as of December 31, 2022). The fair value is estimated on the basis of broker-dealer quotes, which are Level 2 inputs. Accrued interest is included under accrued liabilities and not within the carrying amount or estimated fair value of debt.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 01, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	Commitments and Contingencies Purchase Commitments The Company maintains purchase commitments with certain suppliers, primarily for raw materials, semi-finished goods and manufacturing services and for some non-production items. Purchase commitments for inventory materials are generally restricted to a forecasted time-horizon as mutually agreed upon between the parties. This forecasted time-horizon can vary for different suppliers. As of October 1, 2023, the Company had purchase commitments of $3.9 billion, which are due through 2044 . Our long-term obligations increased substantially in 2021 as we locked in long-term supply with our key manufacturing partners. Legal Proceedings We are regularly involved as plaintiffs or defendants in claims and litigation relating to a variety of matters such as contractual disputes, personal injury claims, employee grievances and intellectual property litigation. In addition, our acquisitions, divestments and financial transactions sometimes result in, or are followed by, claims or litigation. Some of these claims may possibly be recovered from insurance reimbursements. Although the ultimate disposition of asserted claims cannot be predicted with certainty, it is our belief that the outcome of any such claims, either individually or on a combined basis, will not have a material adverse effect on our consolidated financial position. However, such outcomes may be material to our condensed consolidated statement of operations for a particular period. The Company records an accrual for any claim that arises whenever it considers that it is probable that it is exposed to a loss contingency and the amount of the loss contingency can be reasonably estimated. The Company does not record a gain contingency until the period in which all contingencies are resolved and the gain is realized or realizable. Legal fees are expensed when incurred. Impinj Patent Litigation We are involved in a dispute with Impinj, Inc. (“Impinj”) regarding the infringement of IP rights. Impinj has initiated a number of lawsuits alleging infringement of their IP rights by certain of our products and we have initiated a lawsuit and countersuit alleging infringement of our IP rights by certain products of Impinj. Specifically, on June 6, 2019, Impinj filed a complaint against us in the U.S District Court for the Northern District of California (the “Court”) alleging that certain of our products (NXP’s UCODE8 and UCODE 9 integrated circuits) infringed 26 Impinj patents. The case was subsequently narrowed to two patents: U.S. patent nos. 9,633,302 (the “’302 patent”) and 8,115,597 (the “’597 patent”), seeking damages and injunctive relief. Before trial, the Court granted summary judgment of infringement on the ‘302 patent. At trial, on July 14, 2023, the jury returned a verdict finding that NXP infringed the asserted claims of the ‘597 patent. The jury awarde d approximately $19 million in damages. The Court subsequently issued its judgment on October 3, 2023, reducing the award to approximately $13 million, ordering a new trial on the ‘302 patent, and denying Impinj’s request for an injunction based on infringement of the ‘597 patent. NXP intends to appeal the judgment to the United States Court of Appeals for the Federal Circuit. On May 25, 2021, Impinj initiated a lawsuit in the United States District Court for the Western District of Texas (Waco) alleging that certain of our products infringe 9 Impinj patents. NXP countersued alleging that certain products of Impinj infringe 9 patents owned or licensed by NXP. This case commenced into trial beginning October 30, 2023. We dispute Impinj’s claims and intend to continue to pursue available defenses and appeals. We are unable to make a reasonable estimate of losses in excess of the currently accrued amounts given recent developments and future proceedings. Motorola Personal Injury Lawsuits The Company is currently assisting Motorola in the defense of personal injury lawsuits due to indemnity obligations included in the agreement that separated Freescale from Motorola in 2004. The multi-plaintiff Motorola lawsuits are pending in the Circuit Court of Cook County, Illinois. These claims allege a link between working in semiconductor manufacturing clean room facilities and birth defects in 22 individuals. The Motorola suits allege exposures between 1980 and 2005. Each claim seeks an unspecified amount of damages for the alleged injuries; however, legal counsel representing the plaintiffs has indicated they will seek substantial compensatory and punitive damages from Motorola for the entire inventory of claims which, if proven and recovered, the Company considers to be material. A portion of any indemnity due to Motorola will be reimbursed to NXP if Motorola receives an indemnification payment from its insurance coverage. Motorola has potential insurance coverage for many of the years indicated above, but with differing types and levels of coverage, self-insurance retention amounts and deductibles. We are in discussions with Motorola and their insurers regarding the availability of applicable insurance coverage for each of the individual cases. Motorola and NXP have denied liability for these alleged injuries based on numerous defenses. Legal Proceedings Related Accruals and Insurance Coverage The Company reevaluates at least on a quarterly basis the claims that have arisen to determine whether any new accruals need to be made or whether any accruals made need to be adjusted based on the most current information available to it and based on its best estimate. Based on the procedures described above, the Company has an aggregate amount of $114 million accrued for potential and current legal proceedings pending as of October 1, 2023, compared to $58 million accrued at December 31, 2022 (without reduction for any related insurance reimbursements). The accruals are included in “Other current liabilities” and in “Other non-current liabilities”. As of October 1, 2023, the Company’s related balance of insurance reimbursements was $67 million (December 31, 2022: $43 million) and is included in “Other non-current assets”. The Company also estimates the aggregate range of reasonably possible losses in excess of the amount accrued based on currently available information for those cases for which such estimate can be made. The estimated aggregate range requires significant judgment, given the varying stages of the proceedings, the existence of multiple defendants (including the Company) in such claims whose share of liability has yet to be determined, the numerous yet-unresolved issues in many of the claims, and the attendant uncertainty of the various potential outcomes of such claims. Accordingly, the Company’s estimate will change from time to time, and actual losses may be more than the current estimate. As at October 1, 2023, the Company believes that for all litigation pending its potential aggregate exposure to loss in excess of the amount accrued (without reduction for any amounts that may possibly be recovered under insurance programs) could range between $0 and $100 million. Based upon our past experience with these matters, the Company would expect to receive additional insurance reimbursement of up to $70 million on certain of these claims that would partially offset the potential aggregate exposure to loss in excess of the amount accrued.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Pay vs Performance Disclosure
Net income (loss) attributable to stockholders	$ 787	$ 738	$ 2,100	$ 2,065

Significant Accounting Polici_2

Significant Accounting Policies and Recent Accounting Pronouncements (Policies)	9 Months Ended
	Oct. 01, 2023
Accounting Policies [Abstract]
Recently adopted accounting pronouncements	Accounting standards recently adopted In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. ASU 2022-04, which require that a buyer in a supplier finance program to disclose sufficient information about the program, is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. ASU 2022-04 became effective for us on January 1, 2023. We have assessed our current positions and the interrelation to the amendments and the adoption of this update did not have a material impact on the Company's consolidated financial statements and related disclosures. No other new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.

Supplemental Financial Inform_2

Supplemental Financial Information (Tables)	9 Months Ended
	Oct. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Disaggregation of revenue	The following table presents revenue disaggregated by sales channel: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Distributors 1,947 1,876 5,117 5,385 Original Equipment Manufacturers and Electronic Manufacturing Services 1,463 1,525 4,653 4,378 Other 24 44 84 130 Total 3,434 3,445 9,854 9,893
Depreciation Amortization And Impairment Charges [Table Text Block]	For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Depreciation of property, plant and equipment 163 156 485 447 Amortization of internal use software 5 3 14 9 Amortization of other identified intangible assets 105 162 338 492 Total - Depreciation, amortization and impairment 273 321 837 948
Schedule of financial income and expense	For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Interest income 49 21 134 29 Interest expense (109) (109) (329) (319) Total other financial income/ (expense) (15) (10) (36) (41) Total (75) (98) (231) (331)
Schedule of earnings per share	The computation of earnings per share (EPS) is presented in the following table: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Net income (loss) 792 750 2,119 2,099 Less: net income (loss) attributable to non-controlling interests 5 12 19 34 Net income (loss) attributable to stockholders 787 738 2,100 2,065 Weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) 257,488 262,180 258,744 262,620 Plus incremental shares from assumed conversion of: Options 1) 182 275 193 297 Restricted Share Units, Performance Share Units and Equity Rights 2) 3,425 2,250 2,729 1,921 Dilutive potential common shares 3,607 2,525 2,922 2,218 Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) 261,095 264,705 261,666 264,838 EPS attributable to stockholders in $: Basic net income (loss) 3.06 2.81 8.12 7.86 Diluted net income (loss) 3.01 2.79 8.03 7.80 1) There were no stock options to purchase shares of NXP’s common stock that were outstanding in Q3 2023 and YTD 2023 (Q3 2022 and YTD 2022: no shares) that were anti-dilutive and were not included in the computation of diluted EPS because the exercise price was greater than the average fair market value of the common stock or the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense and exercise prices were greater than the weighted average number of shares underlying outstanding stock options. 2) There were no unvested RSUs, PSUs and equity rights that were outstanding in Q3 2023 and YTD 2023 (Q3 2022 and YTD 2022: 0.3 million shares) that were anti-dilutive and were not included in the computation of diluted EPS because the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense were greater than the weighted average number of outstanding unvested RSUs, PSUs and equity rights or the performance goal has not been met yet.
Schedule of inventories	Inventories are summarized as follows: October 1, 2023 December 31, 2022 Raw materials 121 151 Work in process 1,664 1,308 Finished goods 355 323 2,140 1,782
Marketable Securities	At October 1, 2023 and December 31, 2022, the total carrying value of investments in equity securities is summarized as follows: October 1, 2023 December 31, 2022 Marketable equity securities 12 9 Non-marketable equity securities 55 18 Equity-accounted investments 102 71 169 98
Summary of Carrying Value of Investments in Equity-Accounted Investees	The total carrying value of investments in equity-accounted investees is summarized as follows: October 1, 2023 December 31, 2022 Shareholding % Amount Shareholding % Amount SMART Growth Fund, L.P. 8.41 % 41 8.41 % 38 SigmaSense, LLC 10.64 % 34 — — Others — 27 — 33 102 71
Results Relating to Equity-Accounted Investees	Results related to equity-accounted investees at the end of each period were as follows: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Company's share in income (loss) (2) (5) (5) 3 Other results — 1 — 2 (2) (4) (5) 5
Other Current Liabilities	Other current liabilities at October 1, 2023 and December 31, 2022 consisted of the following: October 1, 2023 December 31, 2022 Accrued compensation and benefits 477 467 Customer programs 408 432 Income taxes payable 187 296 Dividend payable 261 219 Other 657 652 1,990 2,066
Schedule of accumulated other comprehensive income (loss)	The after-tax components of accumulated other comprehensive income (loss) and their corresponding changes are shown below: Currency Change in fair Net actuarial Accumulated As of December 31, 2022 135 (1) (58) 76 Other comprehensive income (loss) before (24) (26) — (50) Amounts reclassified out of accumulated other — 10 — 10 Tax effects — 4 — 4 Other comprehensive income (loss) (24) (12) — (36) As of October 1, 2023 111 (13) 58 40
Schedule of cash dividends	The following dividends were declared during the first three quarters of 2023 and 2022 under NXP’s quarterly dividend program: Fiscal year 2023 Fiscal year 2022 Dividend per share Amount Dividend per share Amount First quarter 1.014 263 0.845 222 Second quarter 1.014 263 0.845 222 Third quarter 1.014 261 0.845 221
Schedule of Error Corrections and Prior Period Adjustments	We have reclassified certain amounts related to customer programs previously presented in “Accounts payable” to “Other current liabilities” as of December 31, 2022 to conform to current period presentation as follows: December 31, Accounts payable: As reported 1,617 Reclassification - customer programs (432) Adjusted 1,185 Other current liabilities: As reported 1,634 Reclassification - customer programs 432 Adjusted 2,066

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Oct. 01, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Charges	The following table presents the changes in restructuring liabilities in 2023: As of January 1, 2023 Additions Utilized Released Other As of October 1, 2023 Restructuring liabilities 20 21 (13) (7) (2) 19 These restructuring charges recorded in operating income, for the periods indicated, are included in the following line items in the statement of operations: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Cost of revenue — — (2) (3) Research and development (4) — 10 (2) Selling, general and administrative — — 6 — Net restructuring charges (4) — 14 (5)

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Oct. 01, 2023
Income Tax Disclosure [Abstract]
Schedule of Income Tax Expense (Benefits) and Effective Tax Rates	For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Benefit (provision) for income taxes (123) (149) (399) (392) Effective tax rate 13.4 % 16.5 % 15.8 % 15.8 % Statutory income tax rate in the Netherlands 25.8 % 25.8 % 25.8 % 25.8 %

Identified Intangible Assets (T

Identified Intangible Assets (Tables)	9 Months Ended
	Oct. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Identified Intangible Assets	Identified intangible assets as of October 1, 2023 and December 31, 2022, respectively, were composed of the following: October 1, 2023 December 31, 2022 Gross carrying Accumulated Gross carrying Accumulated In-process R&D (IPR&D) 1) 70 — 70 — Customer-related 788 (341) 788 (307) Technology-based 1,717 (1,224) 2,336 (1,576) Identified intangible assets 2,575 (1,565) 3,194 (1,883) 1) IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort.
Schedule of Estimated Amortization Expense	The estimated amortization expense for these identified intangible assets for each of the five succeeding years is: 2023 (remaining) 101 2024 291 2025 168 2026 88 2027 61 Thereafter 301

Debt (Tables)

Debt (Tables)	9 Months Ended
	Oct. 01, 2023
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	The following table summarizes the outstanding debt as of October 1, 2023 and December 31, 2022: October 1, 2023 December 31, 2022 Maturities Amount Interest Amount Interest Fixed-rate 4.875% senior unsecured notes Mar, 2024 1,000 4.875 1,000 4.875 Fixed-rate 2.7% senior unsecured notes May, 2025 500 2.700 500 2.700 Fixed-rate 5.35% senior unsecured notes Mar, 2026 500 5.350 500 5.350 Fixed-rate 3.875% senior unsecured notes Jun, 2026 750 3.875 750 3.875 Fixed-rate 3.15% senior unsecured notes May, 2027 500 3.150 500 3.150 Fixed-rate 4.40% senior unsecured notes Jun, 2027 500 4.400 500 4.400 Fixed-rate 5.55% senior unsecured notes Dec, 2028 500 5.550 500 5.550 Fixed-rate 4.3% senior unsecured notes Jun, 2029 1,000 4.300 1,000 4.300 Fixed-rate 3.4% senior unsecured notes May, 2030 1,000 3.400 1,000 3.400 Fixed-rate 2.5% senior unsecured notes May, 2031 1,000 2.500 1,000 2.500 Fixed-rate 2.65% senior unsecured notes Feb, 2032 1,000 2.650 1,000 2.650 Fixed-rate 5.00% senior unsecured notes Jan, 2033 1,000 5.000 1,000 5.000 Fixed-rate 3.25% senior unsecured notes May, 2041 1,000 3.250 1,000 3.250 Fixed-rate 3.125% senior unsecured notes Feb, 2042 500 3.125 500 3.125 Fixed-rate 3.25% senior unsecured notes Nov, 2051 500 3.250 500 3.250 Floating-rate revolving credit facility (RCF) Aug, 2027 — — — — Total principal 11,250 11,250 Unamortized discounts, premiums and debt (78) (85) Total debt, including unamortized discounts, 11,172 11,165 Current portion of long-term debt (999) — Long-term debt 10,173 11,165

Related-Party Transactions (Tab

Related-Party Transactions (Tables)	9 Months Ended
	Oct. 01, 2023
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following table presents the amounts related to revenue and other income and purchase of goods and services incurred in transactions with these related parties: For the three months ended For the nine months ended October 1, 2023 October 2, 2022 October 1, 2023 October 2, 2022 Revenue and other income 2 2 3 7 Purchase of goods and services 1 1 2 3
Schedule Of Amounts Receivable From And Payable To Related Parties	The following table presents the amounts related to receivable and payable balances with these related parties: October 1, 2023 December 31, 2022 Receivables 1 1 Payables 7 3

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 01, 2023
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring and Nonrecurring Basis	The following table summarizes the estimated fair value of our financial instruments which are measured at fair value on a recurring basis: Estimated fair value Fair value October 1, 2023 December 31, 2022 Assets: Money market funds 1 3,056 2,817 Marketable equity securities 1 12 9 Derivative instruments-assets 2 1 8 Liabilities: Derivative instruments-liabilities 2 (20) (6)

Acquisitions and Divestments (D

Acquisitions and Divestments (Details) $ in Millions	Jul. 19, 2022 USD ($)
PL Sense
Business Acquisition [Line Items]
Payment to acquire business unit	$ 22.1

Supplemental Financial Inform_3

Supplemental Financial Information - Disaggregation of revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 3,434	$ 3,445	$ 9,854	$ 9,893
Distributors
Disaggregation of Revenue [Line Items]
Revenue	1,947	1,876	5,117	5,385
Original Equipment Manufacturers and Electronic Manufacturing Services
Disaggregation of Revenue [Line Items]
Revenue	1,463	1,525	4,653	4,378
Other
Disaggregation of Revenue [Line Items]
Revenue	$ 24	$ 44	$ 84	$ 130

Supplemental Financial Inform_4

Supplemental Financial Information - Depreciation, amortization and impairment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Finite-Lived Intangible Assets [Line Items]
Depreciation of property, plant and equipment	$ 163	$ 156	$ 485	$ 447
Total - Depreciation, amortization and impairment	273	321	837	948
Internal Use Software
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	5	3	14	9
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 105	$ 162	$ 338	$ 492

Supplemental Financial Inform_5

Supplemental Financial Information - Financial income and expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest income	$ 49	$ 21	$ 134	$ 29
Interest expense	(109)	(109)	(329)	(319)
Total other financial income/ (expense)	(15)	(10)	(36)	(41)
Total	$ (75)	$ (98)	$ (231)	$ (331)

Supplemental Financial Inform_6

Supplemental Financial Information - Earnings per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended						9 Months Ended
	Oct. 01, 2023	Jul. 02, 2023	Apr. 02, 2023	Oct. 02, 2022	Jul. 03, 2022	Apr. 03, 2022	Oct. 01, 2023	Oct. 02, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income (loss)	$ 792	$ 704	$ 623	$ 750	$ 683	$ 666	$ 2,119	$ 2,099
Less: Net income (loss) attributable to non-controlling interests	5			12			19	34
Net income (loss) attributable to stockholders	$ 787			$ 738			$ 2,100	$ 2,065
Basic (in shares)	257,488			262,180			258,744	262,620
Options (in shares)	182			275			193	297
Restricted Share Units, Performance Share Units and Equity Rights (in shares)	3,425			2,250			2,729	1,921
Dilutive potential common shares (in shares)	3,607			2,525			2,922	2,218
Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) (in shares)	261,095			264,705			261,666	264,838
Basic net income (loss) (in dollars per share)	$ 3.06			$ 2.81			$ 8.12	$ 7.86
Diluted net income (loss) (in dollars per share)	$ 3.01			$ 2.79			$ 8.03	$ 7.80
Maximum | Share-based Payment Arrangement, Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0			0			0	0
Maximum | Restricted Stock Units Performance Share Units And Equity Rights
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0			300			0	300

Supplemental Financial Inform_7

Supplemental Financial Information - Cash and cash equivalents (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Dec. 31, 2022
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 4,042		$ 3,845
SSMC
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	225		$ 227
Dividends	$ 0	$ 0
SSMC | TSMC
Cash and Cash Equivalents [Line Items]
Ownership percentage by noncontrolling owners	38.80%

Supplemental Financial Inform_8

Supplemental Financial Information - Inventories (Details) - USD ($) $ in Millions	Oct. 01, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Finished goods under consignment	$ 10	$ 8
Raw materials	121	151
Work in process	1,664	1,308
Finished goods	355	323
Inventory, Net	2,140	1,782
Allowance for obsolescence	$ 153	$ 125

Supplemental Financial Inform_9

Supplemental Financial Information (Details) - Equity investments - USD ($) $ in Millions	Oct. 01, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Marketable equity securities	$ 12	$ 9
Other Investments	55	18
Equity Method Investments	102	71
Investments	$ 169	$ 98

Supplemental Financial Infor_10

Supplemental Financial Information - Other current liabilities (Details) - USD ($) $ in Millions	Oct. 01, 2023	Jul. 02, 2023	Apr. 02, 2023	Dec. 31, 2022	Oct. 02, 2022	Jul. 03, 2022	Apr. 03, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued Employee Benefits, Current	$ 477			$ 467
Customer Funds	408			432
Taxes Payable, Current	187			296
Dividends Payable	261	$ 263	$ 263	219	$ 221	$ 222	$ 222
Other Accrued Liabilities, Current	657			652
Other current liabilities	1,990			2,066
Reclassification [Line Items]
Accounts payable	959			1,185
Other current liabilities	$ 1,990			2,066
As reported
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Other current liabilities				1,634
Reclassification [Line Items]
Accounts payable				1,617
Other current liabilities				1,634
Reclassification, Other
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Other current liabilities				432
Reclassification [Line Items]
Accounts payable				(432)
Other current liabilities				$ 432

Supplemental Financial Infor_11

Supplemental Financial Information - Accumulated other comprehensive income (loss) (Details) $ in Millions	9 Months Ended
	Oct. 01, 2023 USD ($)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 7,740
Other comprehensive income (loss) before reclassifications	(50)
Amounts reclassified out of accumulated other comprehensive income (loss)	10
Other comprehensive income (loss)	4
Other comprehensive income (loss)	(36)
Ending balance	8,798
Currency  translation differences
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	135
Other comprehensive income (loss) before reclassifications	(24)
Amounts reclassified out of accumulated other comprehensive income (loss)	0
Other comprehensive income (loss)	0
Other comprehensive income (loss)	(24)
Ending balance	111
Change in fair  value cash flow hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(1)
Other comprehensive income (loss) before reclassifications	(26)
Amounts reclassified out of accumulated other comprehensive income (loss)	10
Other comprehensive income (loss)	4
Other comprehensive income (loss)	(12)
Ending balance	(13)
Net actuarial gain/(losses)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(58)
Other comprehensive income (loss) before reclassifications	0
Amounts reclassified out of accumulated other comprehensive income (loss)	0
Other comprehensive income (loss)	0
Other comprehensive income (loss)	0
Ending balance	58
Accumulated other comprehensive income (loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	76
Ending balance	$ 40

Supplemental Financial Infor_12

Supplemental Financial Information - Cash dividends (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Oct. 01, 2023	Jul. 02, 2023	Apr. 02, 2023	Oct. 02, 2022	Jul. 03, 2022	Apr. 03, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Dividends common stock (in dollars per share)	$ 1.014	$ 1.014	$ 1.014	$ 0.845	$ 0.845	$ 0.845
Dividends Payable	$ 261	$ 263	$ 263	$ 221	$ 222	$ 222	$ 219

Supplemental Financial Infor_13

Supplemental Financial Information - Summary of carrying value of investments in equity-accounted investees (Details) - USD ($) $ in Millions	Oct. 01, 2023	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	$ 102	$ 71
Wiseroad
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	8.41%	8.41%
Equity Method Investments	$ 41	$ 38
Others
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	0%	0%
Equity Method Investments	$ 27	$ 33
SigmaSense
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	10.64%	0%
Equity Method Investments	$ 34	$ 0

Supplemental Financial Infor_14

Supplemental Financial Information - Results relating to equity-accounted investees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Income Loss from Equity Method Investments Before Extraordinary Items	$ (2)	$ (5)	$ (5)	$ 3
Extraordinary Income Loss From Equity Method Investments	0	1	0	2
Income (Loss) from Equity Method Investments	$ (2)	$ (4)	$ (5)	$ 5

Restructuring - Change in Restr

Restructuring - Change in Restructuring Reserve (Details) $ in Millions	9 Months Ended
	Oct. 01, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance	$ 20
Additions	21
Utilized	(13)
Released	(7)
Other changes	(2)
Restructuring liability, ending balance	$ 19

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ (4)	$ 0	$ 14	$ (5)
Personnel lay-off costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges				$ 0

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Charges Recorded in Operating Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Restructuring Cost and Reserve [Line Items]
Net restructuring charges	$ (4)	$ 0	$ 14	$ (5)
Cost of revenue
Restructuring Cost and Reserve [Line Items]
Net restructuring charges	0	0	(2)	(3)
Research and development
Restructuring Cost and Reserve [Line Items]
Net restructuring charges	(4)	0	10	(2)
Selling, general and administrative
Restructuring Cost and Reserve [Line Items]
Net restructuring charges	$ 0	$ 0	$ 6	$ 0

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Tax Expense (Benefits) and Effective Tax Rate (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022	Oct. 03, 2021
Income Tax Disclosure [Abstract]
Benefit (provision) for income taxes	$ (123)	$ (149)	$ (399)	$ (392)	$ (392)
Effective Income Tax Rate Reconciliation, Percent	13.40%	16.50%	15.80%	15.80%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	25.80%	25.80%	25.80%	25.80%

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Income Tax Disclosure [Abstract]
EstimatedEffectiveIncomeTaxRate	16.10%		16.10%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	25.80%	25.80%	25.80%	25.80%
Effective Income Tax Rate Reconciliation, Percent	13.40%	16.50%	15.80%	15.80%
IncomeTaxReconciliationDiscreteTaxItems	$ 12		$ 8
IncomeTaxReconciliationRecaptureTaxEffect	$ 13

Identified Intangible Assets -

Identified Intangible Assets - Summary of Identified Intangible Assets (Details) - USD ($) $ in Millions	Oct. 01, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	$ 2,575	$ 3,194
Finite-lived intangible assets, accumulated amortization	(1,565)	(1,883)
Customer-related
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	788	788
Finite-lived intangible assets, accumulated amortization	(341)	(307)
Technology-based
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	1,717	2,336
Finite-lived intangible assets, accumulated amortization	(1,224)	(1,576)
In-process R&D (IPR&D)
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, gross carrying amount	$ 70	$ 70

Identified Intangible Assets _2

Identified Intangible Assets - Schedule of Estimated Amortization Expense (Details) - Other Intangible Assets $ in Millions	Oct. 01, 2023 USD ($)
Finite-Lived Intangible Assets [Line Items]
2023	$ 101
2024	291
2025	168
2026	88
2027	61
Thereafter	$ 301

Identified Intangible Assets _3

Identified Intangible Assets - Narrative (Details)	3 Months Ended	9 Months Ended
	Apr. 02, 2023	Oct. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Expected weighted average remaining life of identified intangibles	4 years	4 years

Debt - Schedule of Outstanding

Debt - Schedule of Outstanding Debt (Details) - USD ($) $ in Millions	Oct. 01, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 11,250	$ 11,250
Unamortized discounts, premiums and debt issuance costs	(78)	(85)
Total debt, including unamortized discounts, premiums, debt issuance costs and fair value adjustments	11,172	11,165
Current portion of long-term debt	(999)	0
Long-term debt	10,173	11,165
Unsecured Debt | Fixed-rate 4.875% senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	4.875%	4.875%
Unsecured Debt | Fixed-rate 2.7% senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 500	$ 500
Debt Instrument, Interest Rate, Stated Percentage	2.70%	2.70%
Unsecured Debt | Fixed-rate 5.35% senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 500	$ 500
Debt Instrument, Interest Rate, Stated Percentage	5.35%	5.35%
Unsecured Debt | Fixed-rate 3.875% senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 750	$ 750
Debt Instrument, Interest Rate, Stated Percentage	3.875%	3.875%
Unsecured Debt | Fixed-rate 3.15% senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 500	$ 500
Debt Instrument, Interest Rate, Stated Percentage	3.15%	3.15%
Unsecured Debt | Fixed-Rate 4.4% Senior Unsecured Notes, Maturing May 2027
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 500	$ 500
Debt Instrument, Interest Rate, Stated Percentage	4.40%	4.40%
Unsecured Debt | Fixed-rate 5.55% senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 500	$ 500
Debt Instrument, Interest Rate, Stated Percentage	5.55%	5.55%
Unsecured Debt | Fixed-rate 4.3% senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	4.30%	4.30%
Unsecured Debt | Fixed-rate 3.4% senior unsecured notes
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	3.40%	3.40%
Unsecured Debt | Fixed-Rate 2.5% Senior Unsecured Notes, Maturing May 2031
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	2.50%	2.50%
Unsecured Debt | Fixed-Rate 2.65% Senior Unsecured Notes, Maturing February 2032
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	2.65%	2.65%
Unsecured Debt | Fixed-Rate 5.0% Senior Unsecured Notes, Maturing May 2033
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	5%	5%
Unsecured Debt | Fixed-Rate 3.25% Senior Unsecured Notes, Maturing May 2041
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	3.25%	3.25%
Unsecured Debt | Fixed-Rate 3.125% Senior Unsecured Notes, Maturing February 2042
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 500	$ 500
Debt Instrument, Interest Rate, Stated Percentage	3.125%	3.125%
Unsecured Debt | Fixed-Rate 3.25% Senior Unsecured Notes, Maturing November 2051
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 500	$ 500
Debt Instrument, Interest Rate, Stated Percentage	3.25%	3.25%
Revolving Credit Facility | Floating-rate revolving credit facility (RCF)
Debt Instrument [Line Items]
Debt instrument, principal amount	$ 0	$ 0
Debt Instrument, Interest Rate, Stated Percentage	0%	0%

Related-Party Transactions - Sc

Related-Party Transactions - Schedule of Amounts Related to Revenue and Other Income and Purchase of Goods and Services Incurred in Transactions (Details) - Related Party - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 01, 2023	Oct. 02, 2022	Oct. 01, 2023	Oct. 02, 2022
Related Party Transaction [Line Items]
Revenue and other income	$ 2	$ 2	$ 3	$ 7
Purchase of goods and services	$ 1	$ 1	$ 2	$ 3

Related-Party Transactions - _2

Related-Party Transactions - Schedule of Amounts Related to Receivable and Payable Balances with Related Parties (Details) - Related Party - USD ($) $ in Millions	Oct. 01, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Receivables	$ 1	$ 1
Payables	$ 7	$ 3

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Financial Instruments (Details) - USD ($) $ in Millions	Oct. 01, 2023	Dec. 31, 2022
Assets:
Marketable equity securities	$ 12	$ 9
Estimate of Fair Value Measurement | Level 1
Assets:
Marketable equity securities	12	9
Estimate of Fair Value Measurement | Level 2
Assets:
Derivative instruments-assets	1	8
Liabilities:
Derivative instruments-liabilities	(20)	(6)
Estimate of Fair Value Measurement | Money market funds | Level 1
Assets:
Money market funds	$ 3,056	$ 2,817

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Oct. 01, 2023	Dec. 31, 2022
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Long-term debt	$ 10,173	$ 11,165
Level 2 | Estimate of Fair Value Measurement
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Long-term debt	$ 9,600	$ 9,800

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions					9 Months Ended
	Oct. 03, 2023 USD ($)	Jul. 14, 2023 USD ($)	May 25, 2021 business	Jun. 06, 2019 business	Oct. 01, 2023 USD ($) business individual	Dec. 31, 2022 USD ($)
Commitments and Contingencies [Line Items]
Purchase Obligation					$ 3,900
Loss Contingency, Patents Allegedly Infringed, Number | business			9	26	2
Number of birth defect individuals | individual					22
Accrued potential and legal fees					$ 114	$ 58
Insurance reimbursements					67	$ 43
Insurance reimbursement of claims potential maximum exposure					$ 70
Gain Contingency, Patents Allegedly Infringed upon, Number | business					9
Impinj
Commitments and Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 19
Impinj | Subsequent Event
Commitments and Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 13
Minimum
Commitments and Contingencies [Line Items]
Range of possible loss					$ 0
Maximum
Commitments and Contingencies [Line Items]
Range of possible loss					$ 100